**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 102-27-2 |N-Ethyl-m-toluidine | 99+ | 203-019-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 23/24/25
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Effects may be delayed 2 to 4 hours. Overexposure may
cause methemoglobinemia. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled. Can
produce delayed pulmonary edema. Inhalation at high concentrations
may cause CNS depression and asphixiation.
Chronic:
Prolonged or repeated skin contact may cause dermatitis. May cause
methemoglobinemia, which is characterized by chocolate-brown colored
blood, headache, weakness, dizziness, breath shortness, cyanosis
(bluish skin due to deficient oxygenation of blood), rapid heart
rate, unconsciousness and possible death.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively. Effects may be delayed.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Water may be ineffective.
Material is lighter than water and a fire may be spread by the use of
water. Combustible liquid. Vapors may be heavier than air. They can
spread along the ground and collect in low or confined areas.
Containers may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray,
dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Empty containers retain product
residue, (liquid and/or vapor), and can be dangerous. Keep container
tightly closed. Keep away from heat, sparks and flame. Avoid
ingestion and inhalation. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or
open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Exposure Limits
CAS# 102-27-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear slightly yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 221 deg C @ 760.00 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 89 deg C ( 192.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 0.9570 g/cm3
Molecular Formula: C9H13N
Molecular Weight: 135.21
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat.
Incompatibilities with Other Materials:
Acid anhydrides, acid chlorides, acids, chloroformates, strong
oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 102-27-2: CY0440000
LD50/LC50:
CAS# 102-27-2: Oral, mouse: LD50 = 280 mg/kg; Oral, rat: LD50 = 580
mg/kg.
Oral, rat: LD50 = 580
Carcinogenicity:
N-Ethyl-m-toluidine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: N-ETHYLTOLUIDINES
Hazard Class: 6.1
UN Number: 2754
Packing Group: II
IMO
Shipping Name: N-ETHYLTOLUIDINES
Hazard Class: 6.1
UN Number: 2754
Packing Group: II
RID/ADR
Shipping Name: N-ETHYLTOLUIDINES
Hazard Class: 6.1
UN Number: 2754
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 102-27-2: 1
Canada
CAS# 102-27-2 is listed on Canada's DSL List.
CAS# 102-27-2 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 102-27-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ytterbium, 99,9%, -12 mm
| 7440-64-4 |
|
5-Chloro-1-indanone, 98%
| 42348-86-7 |
|
2-Methyl-1-butanethiol, 95%
| 1878-18-8 |
|
2-Methyl-3-Nitrobenzyl Chloride
| 60468-54-4 |
|
3-Methoxypropylamine, 99+%
| 5332-73-0 |
|
Eicosane, 99%
| 112-95-8 |
|
3-Benzylpyridine, 97%
| 620-95-1 |
|
Chloro-(chloromethyl)-dimethylsilane, 98%
| 1719-57-9 |
|
Rhodium on 1/8-inch alumina pellets ( 0.5% rh)
| |
|
3-Methyl-1-hexene, 99%
| 3404-61-3 |
|
4-Fluorobenzimidazole-2-carboxylic acid
| 83431-74-7 |
|
(S)-(-)-5-(Hydroxymethyl)-2(5H)-furanone, 99% (99% e.e.)
| 78508-96-0 |
|
2-Acetylthiophene, 98%, Balance Mainly 3-Acetylthiophene
| 88-15-3 |
|
Phenylphosphinic acid sodium salt (50% aqueous solution), 46% (titr.)
| 4297-95-4 |
|
m-(Hydrazinosulfonyl)benzoic acid, 99%
| 7385-52-6 |
|
2-Hydroxyquinoline, 99% (UV-VIS)
| 59-31-4 |
|
Acrylamido Glycolic Acid, Anhydrous, 98%
| 6737-24-2 |
|
Naphthalene-d8, 98+ atom % D
| 1146-65-2 |
|
N-Ethyl-m-toluidine, 99+%
| 102-27-2 |
|
Thiazole, 99%
| 288-47-1 |
|
Ferrozine Iron Reagent, Monohydrate, 95+% (UV-Vis)
| 69898-45-9 |
|
1-(4-Methoxyphenyl)-2-methylpiperazine
| 35947-12-7 |
|
7-(2-Chloroethyl)-Theophylline, 97%
| 5878-61-5 |
|
Ammonium Hexabromoplatinate(IV), 99.99%
| 17363-02-9 |
|
2,3-Dibromopropanol, 96%
| 96-13-9 |
|
4-(Methylamino)butyric acid hydrochloride, 99%
| 6976-17-6 |
|
1,3-Propanediol, 98%
| 504-63-2 |
|
2-Fluorobenzylamine, 96%
| 89-99-6 |
|
L-Arabinose
| 5328-37-0 |
|
4-N,N-Dimethylaminoazobenzene-4'-isothiocyanate
| 7612-98-8 |
|
DL-aspartic acid magnesium salt tetrahydrate, 98%
| 215528-79-3 |
|
2-(Diisopropylamino)ethyl Chloride Hydro-Chloride, 97%
| 4261-68-1 |
|
5-Methoxysalicylic Acid, 98%
| 2612-02-4 |
|
1,2-Benzisoxazole, 95%
| 271-95-4 |
|
2,2'-(1,2-Ethenediyldi-4,1-Phenylene)- Bisbenzoxazole
| 1533-45-5 |
|
6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline-1-Thione, 99%
| 24456-59-5 |
|
3,3'-Dichloropivalic Acid, 99%
| 67329-11-7 |
|
3-Indoleacrylic acid, 99%
| 1204-06-4 |
|
1,2,3,6,7,8-Hexahydropyrene,98%
| 1732-13-4 |
|
9H-fluorene-4-carboxylic acid, 96%
| 6954-55-8 |
|
Methylamine Hydrochloride, P.A.
| 593-51-1 |
|
Potassium superoxide (chunks)
| 12030-88-5 |
|
N-Methyl-N-(trimethylsilyl)acetamide, 99%
| 7449-74-3 |
|
1-[4,4-Bis(4-fluorophenyl)butyl]piperazine
| 5631-35-6 |
|
2-(2-Hydroxyethyl)Pyridine, 99%
| 103-74-2 |
|
Scandium(iii)nitrate hydrate, 99.9%
| |
|
9,10-Diphenylanthracene, 99%
| 1499-10-1 |
|
Nocodazole 99+%
| 31430-18-9 |
|
1-Octanesulfonic Acid Sodium Salt, 99+%, HPLC Grade anhydrous
| 5324-84-5 |
|
Barium perchlorate, anhydrous, 99%
| 13465-95-7 |
|
|